Influence of Pentoxifylline on Renal Function in HIV-Scropositive Patients

References

• Gabuzda DH. Neurologic disorders associated with HIV infections. J Am Acad Dermatol 1990; 22: 1232–1236
   Google Scholar
• Engstrom RE, Jr., Holland G. N., Hardy W. D., Meiselman HJ. He-morheologic abnormalities in patients with human immunodeficiency virus infection and ophthalmic microvasculopathy. Am J Ophthalmol 1990; 109: 153–161
   PubMedGoogle Scholar
• Luke D. R., Sarnoski T. P., Dennis S. Incidence of microalbuminuria in ambulatory patients with acquired immunodeficiency syndrome. Clin Sephrol, In press.
   Google Scholar
• Aviado D. M., Dettelbach HR. Pharmacology of pentoxifylline. A hemorheologic agent for the treatment of intermittent claudica-tion. Angiology 1984; 35: 407–417
   PubMed Web of Science ®Google Scholar
• Ellermann J., Gründer W., Keller T. Effect of pentoxifylline on the ischemic rat kidney monitored by 31P NMR spectroscopy. in vivo. Biomed Biochim Acta 1988; 47: 515–521
   PubMedGoogle Scholar
• Berens K. L., Luke DR. Pentoxifylline in the isolated perfused rat kidney. Transplantation 1990; 49: 876–879
   PubMed Web of Science ®Google Scholar
• Luke D. R., Berens K. L., Verani RR. Role of vascular congestion in ischemic acute renal failure. Renal Failure 1989–90; 11: 187–194
   PubMed Web of Science ®Google Scholar
• Berens K. L., Langston J. D., Wasan K. M., Luke DR. Influence of pentoxifylline and related analogues in endotoxemic renal failure. Circ Shock 1991; 34: 344–348
   PubMedGoogle Scholar
• Luke D. R., Wasan K. M., McQueen T. J., Lopez-Berestein G. Enhancement of the treatment of experimental candidiasis with vascular decongestants. J Infect Dis 1990; 162: 211–214
   Google Scholar
• Wasan K. M., Vadiei K., Luke D. R., Keyhani A., White A. R., McQueen T. J., Mehta R., Lopez-Berestein G. Antifungal activity of HWA-138 and amphotericin-B in experimental systemic candidiasis. Antimicrob Agents Chemother 1991; 35: 2046–2048
   PubMed Web of Science ®Google Scholar
• Brunner L. J., Vadiei K., Iyer L. V., Luke DR. Prevention of cyclosporine-induced nephrotoxicity with pentoxifylline. Renal Failure 1989; 11: 97–104
   PubMed Web of Science ®Google Scholar
• Bianco J. A., Almgren J., Kern D. L., Ballard B., Roark K., Andrews F., Nemunaitis J., Shields T., Singer JW. Evidence that oral pentoxifylline reverses acute renal dysfunction in bone marrow transplant recipients receiving amphotericin B and cyclosporine. Results of a pilot study. Transplantation 1991; 51: 925–927
   PubMed Web of Science ®Google Scholar
• Wasan K. M., Vadiei K., Lopez-Berestein G., Verani R. R., Luke DR. Pentoxifylline in amphotericin B toxicity rat model. Antimicrob Agent Chemother 1990; 34: 241–244
   PubMed Web of Science ®Google Scholar
• Luke D. R., Wasan K. M., Verani R. R., Brunner L. J., Berens K. L., Vadiei K., Lopez-Berestein G. Attenuation of amphotericin-B nephrotoxicity in the candidiasis rat model. Nephron 1991; 59: 139–144
   PubMed Web of Science ®Google Scholar
• Luke D. R., Berens K. L., Verani RR. Benefit of vascular deconges-tion in glycerol-induced acute renal failure. Renal Failure 1991; 13: 61–69
   PubMed Web of Science ®Google Scholar
• Vadiei K., Brunner L. J., Luke DR. Effects of pentoxifylline in experimental acute renal failure. Kidney Int 1989; 36: 466–470
   PubMed Web of Science ®Google Scholar
• Berens K. L., Verani R. R., Luke DR. The role of glomerular polymorphonuclear (PMN) leukocytes in nephrotic syndrome. Presented at the 7th Annual Meeting of American Association of Pharmaceutical Scientists. Alexandria, VA November, 1991
   Google Scholar
• Berens K. L., Luke DR. Hemorheologic involvement ofmurine diabetic nephropathy. Presented at the 93rd Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics. Orlando, FL March, 1992
   Google Scholar
• Ely H. White blood cells as mediators of hyperviscosity-induced tissue damage in neutrophilic vascular reactions: Therapy with pentoxifylline. J Am Acad Dermatol 1989; 20: 677–680
   PubMed Web of Science ®Google Scholar
• Fazely F., Dezube B. J., Allen-Ryan J., Pardee A. B., Ruprecht RM. Pentoxifylline (Trentalr`) decreases the replication of the human immunodeficiency virus Type I in human peripheral blood mononuclear cells and in cultured T cells. Blood 1991; 77: 1653–1656
   PubMed Web of Science ®Google Scholar
• Luke D. R., Vadiei K., Lopez-Berestein G. Role of vascular congestion in cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 1992; 7: 1–7
   PubMed Web of Science ®Google Scholar
• Sullivan G. W., Carper H. T., Novick WJ, Jr., Mandell GL. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Im-mun 1988; 56: 1722–1729
   PubMed Web of Science ®Google Scholar
• Vyakarnam A., McKeating J., Meager A., Beverley PC. Tumor necrosis factor (a,β) induced by HIV-1 peripheral blood mononuclear cells potentiate virus replication. AIDS 1990; 4: 21–27
   PubMed Web of Science ®Google Scholar
• Osborn L., Kunkel S., Nabel GJ. Tumor necrosis factor a and in-terleukin I stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc Natl Acad Sci USA 1989; 86: 2336–2340
   PubMed Web of Science ®Google Scholar
• Reddy M. M., Sorrell S. J., Lange M., Grieco MH. Tumor necrosis factor and HIV p24 antigen levels in serum of HIV-infected populations. J Acq Immune Def Syn 1988; 1: 436–440
   PubMed Web of Science ®Google Scholar
• Maury CPJ, Lahdevirta J. Correlation of serum cytokine levels with hematological abnormalities in human immunodeficiency virus infection. J Int Med 1990; 227: 253–257
   Google Scholar
• Beermann B., Ings R., Månsby J., Chamberlain J., McDonald A. Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther 1985; 37: 25–28
   PubMed Web of Science ®Google Scholar
• Cello JP. Gastrointestinal manifestations of HIV infection. Infect Dis Clin North Am 1988; 2: 387–396
   Google Scholar
• van der Ven A. J., Koopmans P. P., Vree T. B., van der Meer JW. Adverse reactions to co-trimoxazole in HIV infection. Lancet 1991; 338: 431–433
   Google Scholar